02.05.15
Cambridge, Mass.-based InVivo Therapeutics Holdings Corp. had appointed Mark D. Perrin as chairman of its board of directors, effective immediately. Perrin has served as a board member and CEO of the company since January 2014. John A. McCarthy, Jr., current non-executive chairman of the board since September 2013, will remain on the board and will continue to chair the audit committee.
“Given the significant transformation of the company over the past year under Mark’s leadership as CEO, the board and I felt it was appropriate timing to now unify the chairman and CEO roles,” said John McCarthy. “Our decision was made to promote consistent and unified leadership, timely decision-making, strategy development, and execution.”
“I look forward to taking on the challenges of board chair,” Mark Perrin said, adding that the entire board wishes to acknowledge John’s significant contributions over the past transformative year. “We all appreciate John’s broad input and expertise, and we know his support for InVivo’s future will be important as we move ahead with the Neuro-Spinal Scaffold and other development programs.”
InVivo is a biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.
“Given the significant transformation of the company over the past year under Mark’s leadership as CEO, the board and I felt it was appropriate timing to now unify the chairman and CEO roles,” said John McCarthy. “Our decision was made to promote consistent and unified leadership, timely decision-making, strategy development, and execution.”
“I look forward to taking on the challenges of board chair,” Mark Perrin said, adding that the entire board wishes to acknowledge John’s significant contributions over the past transformative year. “We all appreciate John’s broad input and expertise, and we know his support for InVivo’s future will be important as we move ahead with the Neuro-Spinal Scaffold and other development programs.”
InVivo is a biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.